Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1974 1
1975 1
1976 1
1979 1
1980 1
1983 1
1984 1
1985 1
1986 2
1990 7
1991 2
1992 3
1993 1
1994 2
1995 5
1996 5
1997 5
1998 1
1999 7
2000 5
2001 6
2002 6
2003 3
2004 4
2005 5
2006 6
2007 11
2008 9
2009 4
2010 12
2011 14
2012 16
2013 31
2014 36
2015 22
2016 35
2017 38
2018 30
2019 41
2020 31
2021 34
2022 30
2023 24
2024 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Results by year

Filters applied: . Clear all
Page 1
Retraction notice to "Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The Perfect-CR study☆" [International journal of Cardiology 371C (2022) 40-48].
Michelsen HÖ, Henriksson P, Wallert J, Bäck M, Sjölin I, Schlyter M, Hagström E, Kiessling A, Held C, Hag E, Nilsson L, Schiopu A, Zaman MJ, Leosdottir M. Michelsen HÖ, et al. Among authors: held c. Int J Cardiol. 2024 Dec 5:132876. doi: 10.1016/j.ijcard.2024.132876. Online ahead of print. Int J Cardiol. 2024. PMID: 39643567 No abstract available.
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial.
Erlinge D, Andersson J, Fröbert O, Törnerud M, Hamid M, Kellerth T, Grimfjärd P, Winnberg O, Jurga J, Wagner H, Zwackman S, Adielsson M, Alström P, Masoe E, Ulvenstam A, Millgård J, Böhm F, Held C, Renlund H, Oldgren J, Smits PC, Elek C, Abizaid A, James S. Erlinge D, et al. Among authors: held c. Lancet. 2024 Nov 2;404(10464):1750-1759. doi: 10.1016/S0140-6736(24)02227-X. Epub 2024 Oct 28. Lancet. 2024. PMID: 39481425 Clinical Trial.
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial.
Leissner P, Mars K, Humphries S, Karlström P, Yndigegn T, Jernberg T, Hofmann R, Held C, Olsson EMG. Leissner P, et al. Among authors: held c. Eur Heart J Acute Cardiovasc Care. 2024 Oct 3:zuae112. doi: 10.1093/ehjacc/zuae112. Online ahead of print. Eur Heart J Acute Cardiovasc Care. 2024. PMID: 39422765
Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy.
Kjøller-Hansen L, Maehara A, Kelbæk H, Matsumura M, Maeng M, Engstrøm T, Fröbert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Omerovic E, Held C, James S, Mintz GS, Ali ZA, Stone GW, Erlinge D. Kjøller-Hansen L, et al. Among authors: held c. Circ Cardiovasc Interv. 2024 Oct;17(10):e014215. doi: 10.1161/CIRCINTERVENTIONS.124.014215. Epub 2024 Sep 25. Circ Cardiovasc Interv. 2024. PMID: 39319453
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design.
Lund LH, James S, DeVore AD, Anstrom KJ, Fudim M, Aaronson KD, Dahlström U, Desvigne-Nickens P, Fleg JL, Yang S, Fu M, Hage C, Held C, Karlström P, Nygren M, Peterson ED, Pol T, Sapp S, Sundström J, Östlund O, Oldgren J, Pitt B. Lund LH, et al. Among authors: held c. Eur J Heart Fail. 2024 Sep 16. doi: 10.1002/ejhf.3453. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39282788
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMI.
Mars K, Humphries S, Leissner P, Jonsson M, Karlström P, Lauermann J, Alfredsson J, Kellerth T, Ravn-Fischer A, Erlinge D, Lindahl B, Yndigegn T, Jernberg T, Held C, Olsson EMG, Hofmann R. Mars K, et al. Among authors: held c. Eur Heart J Cardiovasc Pharmacother. 2024 Sep 1:pvae062. doi: 10.1093/ehjcvp/pvae062. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39217445
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent.
Erlinge D, Andersson J, Fröbert O, Törnerud M, Böhm F, Held C, Elek C, Sirhan M, Oldgren J, James S. Erlinge D, et al. Among authors: held c. Am Heart J. 2024 Nov;277:1-10. doi: 10.1016/j.ahj.2024.07.016. Epub 2024 Aug 2. Am Heart J. 2024. PMID: 39098754 Free article. Clinical Trial.
467 results